Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more
9/14/2021
Copy link to Clipboard

Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the September 14, 2021 issue.

Bullhorn
(519)